Indivumed and the Institute of Molecular and Cell Biology (IMCB) of Singapore’s Agency for Science, Technology and Research (A*STAR) said today they will build what they said was the first global multiomics cancer database. The value of the collaboration was not disclosed. The partners said they have agreed to carry…

Precision Therapeutics said today it agreed to acquire all shares of Helomics, up from its current 25% stake, in a deal designed to catapult the buyer into leadership in precision oncology. Minneapolis-based Precision Therapeutics has signed a letter of intent to buy the remaining Helomics shares it did not currently…

Metabolon said today it will perform large-scale metabolomic profiling on biological samples from U.S. veterans as part of the Million Veteran Program, through the company’s partnership with genomics services provider AKESOgen. The Million Veteran Program (MVP), a research effort launched by the U.S. Department of Veterans Affairs in 2011, is…

DNAnexus, the developer of a cloud-based genome informatics and data management platform, said today it has closed on a $58 million financing intended to accelerate the company’s expansion in translational informatics, clinical trials, and broadened use of biomedical data. New investor Foresite Capital led the equity financing, with strategic investment…

Indivumed and Helomics said today they will analyze human cancer biospecimens and annotated clinical data from consenting patients worldwide, through a collaboration designed to enable basic and translational research through the development of biomarkers. The collaboration, whose value was not disclosed, will combine Indivumed's global cancer database, biobank and research…

The European market for next-generation sequencing (NGS) informatics is set to more than double by 2021, driven by the data deluge resulting from falling sequencing costs, electronic health records, and wider use of data in clinical interpretation, according to a new report by Frost & Sullivan. “Growth Opportunities in the…

Precision medicine company Perthera has announced a partnership with the non-profit patient support organization Hope for Stomach Cancer that will see Perthera’s Precision Cancer Analysis (PCA) service provided to all Hope for Stomach Cancer patients at no cost to them. PCA is a service that brings together a variety of CLIA/CAP…

Researchers at the University of California San Diego (UCSD) School of Medicine have just identified key proteins significantly altered at the gene-expression level in biopsied tissue from patients with diabetic kidney disease while using a new bioinformatic framework—a result that may reveal new therapeutic targets. The findings from this new…

Tailoring healthcare decisions based on biological information represents the promise of personalized medicine. A key hurdle slowing progress toward tailored therapeutics is developing appropriate biomarkers for diagnostics, prognostics, and prediction. Despite much research, only a trickle of biomarkers has made it into clinical practice. Researchers, however, are pursuing novel avenues…

Vural Özdemir, M.D., Ph.D., is editor-in-chief of OMICS: A Journal of Integrative Biology, published by Mary Ann Liebert, Inc. He is also an associate professor of human genetics at the council of higher education in Ankara, Turkey, and an independent scholar in science studies and advisor to the office of…